CA2255521A1 - Compositions for treatment of burns - Google Patents

Compositions for treatment of burns Download PDF

Info

Publication number
CA2255521A1
CA2255521A1 CA002255521A CA2255521A CA2255521A1 CA 2255521 A1 CA2255521 A1 CA 2255521A1 CA 002255521 A CA002255521 A CA 002255521A CA 2255521 A CA2255521 A CA 2255521A CA 2255521 A1 CA2255521 A1 CA 2255521A1
Authority
CA
Canada
Prior art keywords
composition
agents
weak organic
burns
organic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002255521A
Other languages
French (fr)
Other versions
CA2255521C (en
Inventor
H. Michael Dosch
Xiaomao Li
Kurt Ostermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Palladin Healthcare International Ltd
Original Assignee
Palladin Healthcare International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Palladin Healthcare International Ltd filed Critical Palladin Healthcare International Ltd
Priority to CA002255521A priority Critical patent/CA2255521C/en
Publication of CA2255521A1 publication Critical patent/CA2255521A1/en
Priority to US10/232,080 priority patent/US7012096B2/en
Application granted granted Critical
Publication of CA2255521C publication Critical patent/CA2255521C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/21—Acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

The present invention is directed to a composition for treating burns. The composition comprises a therapeutically effective amount of a weak organic acid compatible with human skin, in a suitable carrier delivered at pH 2.5-4.5. The weak organic acid is preferably acetic acid or citric acid and the suitable carrier is preferably an aqueous based carrier, more preferably a gel form, utilizing a Carbopol.TM. as a gelling agent. The composition may also include one or more other agents selected from sun blocking agents, skin moisturizing agents and herb extracts.
CA002255521A 1998-12-09 1998-12-09 Compositions for treatment of burns Expired - Fee Related CA2255521C (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA002255521A CA2255521C (en) 1998-12-09 1998-12-09 Compositions for treatment of burns
US10/232,080 US7012096B2 (en) 1998-12-09 2002-08-30 Composition for pain mediation and apparatus and method of use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002255521A CA2255521C (en) 1998-12-09 1998-12-09 Compositions for treatment of burns

Publications (2)

Publication Number Publication Date
CA2255521A1 true CA2255521A1 (en) 2000-06-09
CA2255521C CA2255521C (en) 2008-11-04

Family

ID=29425799

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002255521A Expired - Fee Related CA2255521C (en) 1998-12-09 1998-12-09 Compositions for treatment of burns

Country Status (1)

Country Link
CA (1) CA2255521C (en)

Also Published As

Publication number Publication date
CA2255521C (en) 2008-11-04

Similar Documents

Publication Publication Date Title
MXPA02012075A (en) Composition for pain mediation and apparatus and method of use thereof.
MY135988A (en) Additive for improving the water resistance of cosmetic or dermatological formulations
WO1998010767A3 (en) Use of quinazoline derivatives for the manufacture of a medicament in the treatment of hyperproliferative skin disorders
NZ295211A (en) Topical aqueous gel containing a water-soluble cellulose derivative, propylene glycol & drug(s) for haemorrhoids
CA2252900A1 (en) Cosmetic composition for rejuvenation of skin without skin irritation
CA2338091A1 (en) Method of conditioning the skin
EP1041880A4 (en) A delivery of arginine to cause beneficial effects
CA2289717A1 (en) Novel therapy for constipation
CA2404810A1 (en) Topical composition having undifferentiated plant seed cells and method for using same
WO2002019981A3 (en) Cosmetic and pharmaceutical composition comprising chelating/sequestering agents and their cosmetic and dermatological use
CA2373794A1 (en) Compositions and uses of et743 for treating cancer
WO2001030802A3 (en) Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies
CA2271162A1 (en) Stearidonic acid compositions and uses thereof
WO2000018316A3 (en) Sustained release, and comfortable ophthalmic composition and method for ocular therapy
CA2221900A1 (en) Use of trospium chloride and 2-component system for the same
CA2157836A1 (en) L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
CA2326528A1 (en) Cholesterol sulfate compositions for artificial skin tanning
ES2137125A1 (en) Use of the zinc salt of glycyrrhetic acid in preparations against acne, and the compositions which contain said salt.
IL118218A0 (en) Terpenoidic derivatives and pharmaceutical compositions containing them
AU3946197A (en) Cosmetic, dermatological and pharmaceutical use of a terminalia catappa extract
CA2190377A1 (en) Use of topical treatment compositions comprising alpha hydroxy acid in the treatment of striae distensae
WO2001085188A3 (en) Use of echinacea as a hematinic agent
WO2000037037A3 (en) Composition for treatment of burns
CA2255521A1 (en) Compositions for treatment of burns
CA2294482A1 (en) Treatment of aging skin

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed